{
    "clinical_study": {
        "@rank": "52000", 
        "arm_group": [
            {
                "arm_group_label": "PEB", 
                "arm_group_type": "Active Comparator", 
                "description": "PEB angioplasty plus provisional nitinol stent implantation"
            }, 
            {
                "arm_group_label": "PES", 
                "arm_group_type": "Experimental", 
                "description": "Systematic PES angioplasty"
            }
        ], 
        "brief_summary": {
            "textblock": "To determine in patients with symptomatic femoropopliteal lesions whether percutaneous\n      revascularization with paclitaxel-eluting balloon angioplasty (PEB) and provisional nitinol\n      stent is superior with respect to the 12-month incidence of restenosis compared to treatment\n      with systematic paclitaxel-eluting stent (PES) angioplasty"
        }, 
        "brief_title": "Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions", 
        "condition": "Peripheral Artery Disease", 
        "condition_browse": {
            "mesh_term": "Peripheral Arterial Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  intermittent claudication or critical limb ischemia\n\n          -  de novo stenosis \u2265 50% or occlusion of at least 40 mm in length located in\n             femoropopliteal arteries\n\n          -  presence of a clear healthy segment between the lesion in superficial femoral and\n             common femoral artery and between popliteal and tibioperoneal trunk\n\n          -  presence of at least 1 patent tibial vessel with distal run-off (below-the-knee\n             artery was considered patent if free from obstructive lesions determining\n             angiographic stenosis >70%)\n\n        Exclusion Criteria:\n\n          -  life expectancy <1 year\n\n          -  contraindication for combined antiplatelet therapy or known allergy to nickel or\n             paclitaxel\n\n          -  need for major amputation (MA) at the time of enrolment\n\n          -  Failure to recanalize intended below-the-knee arteries in CLI patients at risk of\n             major amputation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01969630", 
            "org_study_id": "Arezzo011"
        }, 
        "intervention": [
            {
                "arm_group_label": "PEB", 
                "description": "Paclitaxel eluting balloon angioplasty plus provisional nitinol stent implantation", 
                "intervention_name": "PEB", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "PES", 
                "description": "Systematic Paclitaxel eluting stent angioplasty", 
                "intervention_name": "PES", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Paclitaxel"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "femoropopliteal lesions", 
        "lastchanged_date": "October 21, 2013", 
        "location": {
            "contact": {
                "email": "francescoliistro@hotmail.com", 
                "last_name": "Francesco Liistro, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Arezzo", 
                    "country": "Italy", 
                    "state": "AR", 
                    "zip": "52100"
                }, 
                "name": "Cardiovascular Department, Ospedale S.Donato"
            }, 
            "investigator": [
                {
                    "last_name": "Leonardo Bolognese, MD, FESC", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Giovanni Falsini, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Paolo Angioli, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Kenneth Ducci, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Francesco Liistro, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Simone Grotti, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Italo Porto, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "incidence of binary restenosis", 
            "measure": "angiographic binary restenosis", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01969630"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ospedale San Donato", 
            "investigator_full_name": "Leonardo Bolognese, MD", 
            "investigator_title": "Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "incidence of composite endpoint of all cause mortality, major amputation and target lesion revascularization.", 
            "measure": "Composite of all cause mortality, major amputation and target lesion revascularization.", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Ospedale San Donato", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ospedale San Donato", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}